Showing results (241-250 of 260) with videos related to
Sort By:
Pageof 26
Acta Reumatologica Portuguesa|July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 updatePedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.Annals of the Rheumatic Diseases|September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registriesManuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.RMD Open|November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registriesLykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.RMD Open|November 8, 2018
Mixed connective tissue disease: state of the art on clinical practice guidelinesBenjamin Chaigne, Carlo Alberto Scirè, Rosaria Talarico, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of RegistriesRomain Aymon, Denis Mongin, Romain Guemara, et al.Current Climate Change Reports|February 7, 2020
Lessons on Climate Sensitivity From Past Climate ChangesAnna S von der Heydt, Henk A Dijkstra, Roderik S W van de Wal, et al.Annals of the Rheumatic Diseases|December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.Acta Reumatologica Portuguesa|November 15, 2012
[Portuguese recommendations for pain management by pharmocotherapy in inflammatory arthritis]Inês Silva, Ana F Mourão, Sofia Ramiro, et al.Pageof 26